wieder verpuffen. Nur um das mal ein wenig zu framen:
But after a “discussion with the FDA, the companies recently elected to drop the 32-case interim analysis and conduct the first interim analysis at a minimum of 62 cases,” Pfizer said in a statement.
However, by the time this had been sorted out, data from 94 patients were used. The trial only started in July but has already enrolled nearly 44,000 patients. It remains ongoing, and Pfizer will need to hit data from 164 patients and build up at least two months’ worth of safety data before it can ask the FDA for an emergency use OK.
Ich weiß nicht ob man anhand von 94 Patienten klar sagen kann, dass der Impfstoff keine Nebenwirkungen hat.